Page last updated: 2024-10-25

cimetidine and Epidermodysplasia Verruciformis

cimetidine has been researched along with Epidermodysplasia Verruciformis in 2 studies

Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.

Epidermodysplasia Verruciformis: An autosomal recessive trait with impaired cell-mediated immunity. About 15 human papillomaviruses are implicated in associated infection, four of which lead to skin neoplasms. The disease begins in childhood with red papules and later spreads over the body as gray or yellow scales.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Micali, G1
Nasca, MR1
Dall'Oglio, F1
Musumeci, ML1
de Oliveira, WR1
Neto, CF1
Rivitti, EA1

Other Studies

2 other studies available for cimetidine and Epidermodysplasia Verruciformis

ArticleYear
Cimetidine therapy for epidermodysplasia verruciformis.
    Journal of the American Academy of Dermatology, 2003, Volume: 48, Issue:2 Suppl

    Topics: Adolescent; Cimetidine; Epidermodysplasia Verruciformis; Histamine H2 Antagonists; Humans; Male; Tre

2003
The lack of a clinical effect of cimetidine in the treatment of epidermodysplasia verruciformis.
    Journal of the American Academy of Dermatology, 2004, Volume: 50, Issue:6

    Topics: Adolescent; Adult; Cimetidine; Epidermodysplasia Verruciformis; Female; Humans; Male; Treatment Outc

2004